Authors
Marci O'Driscoll, Suzanne Silbert, Tashkin Tokaria, Shannon Young, Ashkon Chamani, Daniel Wind, Kimberly Munoz, Jason W Wilson
Published in
Critical care explorations. Volume 8. Issue 11. Pages e1523. Nov 01, 2026. Epub Nov 13, 2026.
Abstract
To evaluate the impact of implementing a host-protein bacterial/viral test in the emergency department (ED) sepsis alert order set.
Pre/postimplementation study. Host-protein testing was automatically ordered both pre- and postimplementation as part of the ED sepsis alert order set; test results were accessible to treating clinicians only postimplementation. The pre- (September 2024 to December 2024) to postimplementation (January 2025 to March 2025) transition also involved education on the host-protein test to ED clinicians. The primary outcome was patient classification into Surviving Sepsis Campaign (SSC) sepsis categories (definite/probable vs. possible vs. unlikely sepsis).
ED of an academic medical center.
Adults who triggered the ED sepsis alert order set.
Host-protein bacterial/viral test (MeMed BV) automatically ordered in ED sepsis alert order set. Test result was only visible to clinicians postimplementation.
There were 893 eligible patients; 505 patients in the preimplementation cohort and 388 in the postimplementation cohort. The distribution of SSC sepsis categories differed between pre- and postimplementation cohorts (χ2(2) = 8.73; p = 0.013). The difference was primarily driven by a larger proportion of patients classified as unlikely sepsis (from 32.5% to 41.1%; p = 0.009) and a smaller proportion classified as possible sepsis (from 18.4% to 13.2%; p = 0.043). Among unlikely sepsis patients, host-protein test implementation was associated with ordering fewer cefepime doses (from 3.3 to 2.2; p = 0.044) and a lower hospitalization rate (from 92.1% to 79.9%; p = 0.002).
These findings support an association between host-protein testing for patients triggering ED sepsis alerts and the distribution of possible vs. unlikely sepsis cases. Multicenter clinical utility studies are warranted.
PMID:
43023823
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0